Oxaliplatin reintroduction in colorectal cancer patients following disease progression after adjuvant oxaliplatin-based chemotherapy

Yongchang Chen(Jiangsu University), Feng‐Hua Wang(Sun Yat-sen University), Xin An(Sun Yat-sen University), Rui‐Hua Xu(Sun Yat-sen University), Chen Cui(Chinese Academy of Medical Sciences & Peking Union Medical College), Le Zhang(Nankai University), Yuhong Li(Southwest Jiaotong University)
Clinical Oncology and Cancer Research
July 15, 2012
10.3969/j.issn.1000-8179.2012.13.013
Cited by 0

Related Papers

Circular RNA: metabolism, functions and interactions with proteins
|Molecular Cancer|2020|1.6k
Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction
|Journal of Clinical Oncology|2016|1k
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
|New England Journal of Medicine|2019|934
METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma
|Molecular Cancer|2019|868
Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma
|JAMA|2021|821